REGENXBIO, Inc. (RGNX)
8.80
-0.16
(-1.79%)
USD |
NASDAQ |
Apr 10, 16:00
8.805
0.00 (0.00%)
After-Hours: 20:00
REGENXBIO Accounts Payable (Quarterly) : 21.36M for Dec. 31, 2025
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Sarepta Therapeutics, Inc. | 280.84M |
| AbbVie, Inc. | 34.42B |
| Replimune Group, Inc. | 5.647M |
| Ocugen, Inc. | 6.202M |
| Krystal Biotech, Inc. | 3.238M |